Dmitry Balyasny’s Compugen CGEN Stock Holding History

Dmitry Balyasny’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$185K	–	2885
2022 Q2	$185K	Buy	+100,000	New	+$216K	﹤0.01%	2216

Other funds holding CGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Dmitry Balyasny's CGEN Position: Q4 2020 in Review

Dmitry Balyasny sold out of Compugen (CGEN) in Q4 2020, closing a stake of 101,711 shares — an estimated $1.65M sold.

Dmitry Balyasny first reported a position in CGEN in Q3 2020 and held it in 1 quarter. The position peaked at $1.65M in Q3 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.

Dmitry Balyasny reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
Dmitry Balyasny sold 101,711 Compugen shares in Q4 2020, an estimated $1.65M.
Dmitry Balyasny first reported a position in Compugen in Q3 2020 and held it in 1 quarter.
Dmitry Balyasny's Compugen position peaked at $1.65M in Q3 2020.
101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.

Based on Balyasny Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.